Immunome, Inc. (IMNM) stock analysis

IMNM · Immunome, Inc.

Latest recorded price: USD 17.61

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: free cash flow margin -2,890.1%, ROIC -102.5%. The model flags 2 risk signals for this company (2 high severity).

Similar companies in Healthcare